
Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: http://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews
We're tracking STAT's market expansion
How STAT's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
STATYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
Sign up for Health Care Inc.
ActiveGet the latest health, policy, and biotech news delivered straight to your fingertips with STAT+, now 40% off for an annual subscription. Subscribe anytime with code MD2026 by May 31 to catch this Memorial Day deal.
ActiveGet the latest health, policy, and biotech news delivered straight to your fingertips with STAT+, now 40% off for an annual subscription. Subscribe anytime with code MD2026 by May 31 to catch this Memorial Day deal.
ActiveIsrael escalates attacks on Iran, US debates involvement, domestic issues include national park controversies, Juneteenth reflections, and health developments.
Bausch & Lomb's dry eye drug Miebo costs $800 in the US but is available OTC in Europe for $20 as EvoTears.
Covers Russian forces in Venezuela, Fed subpoena, NIH resignations, food pyramid changes, social media influencers as lobbyists, AI copyright issues, and cultural topics.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about STAT's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.